Mercer Global Advisors’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,580
Closed -$353K 1971
2022
Q3
$353K Sell
5,580
-91
-2% -$6.32K ﹤0.01% 1323
2022
Q2
$396K Sell
5,671
-1,560
-22% -$109K ﹤0.01% 1274
2022
Q1
$508K Buy
7,231
+677
+10% +$45.5K ﹤0.01% 1225
2021
Q4
$445K Buy
6,554
+229
+4% +$15.8K ﹤0.01% 1267
2021
Q3
$443K Sell
6,325
-80
-1% -$5.82K ﹤0.01% 1229
2021
Q2
$448K Sell
6,405
-734
-10% -$53.3K ﹤0.01% 1198
2021
Q1
$556K Buy
7,139
+3,372
+90% +$239K 0.01% 1038
2020
Q4
$250K Buy
3,767
+115
+3% +$7.58K ﹤0.01% 1146
2020
Q3
$228K Buy
3,652
+371
+11% +$23.2K ﹤0.01% 1066
2020
Q2
$208K Buy
3,281
+406
+14% +$27.2K ﹤0.01% 990
2020
Q1
$206K Buy
2,875
+550
+24% +$43.5K ﹤0.01% 937
2019
Q4
$201K Buy
+2,325
New +$194K ﹤0.01% 1084

Other funds holding NHC

Mercer Global Advisors's NHC Position: Q4 2022 in Review

Mercer Global Advisors sold out of National Healthcare (NHC) in Q4 2022, closing a stake of 5,580 shares — an estimated $353K sold.

Mercer Global Advisors first reported a position in NHC in Q4 2019 and held it in 12 quarters. The position peaked at $556K in Q1 2021. 118 funds tracked by Wall St. Rank hold NHC as of Q4 2022.

  • Mercer Global Advisors reported no remaining National Healthcare position as of Q4 2022 after selling out during the quarter.
  • Mercer Global Advisors sold 5,580 National Healthcare shares in Q4 2022, an estimated $353K.
  • Mercer Global Advisors first reported a position in National Healthcare in Q4 2019 and held it in 12 quarters.
  • Mercer Global Advisors's National Healthcare position peaked at $556K in Q1 2021.
  • 118 funds tracked by Wall St. Rank held National Healthcare as of Q4 2022.

Based on Mercer Global Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.